Compare DexCom, Inc. (DXCM) vs Walmart Stores Inc (WMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Walmart Stores Inc — how do they compare? DexCom, Inc. trades at $77.28 (market cap $28.06B), while Walmart Stores Inc trades at $115.01 (market cap $895.52B). The key difference: Walmart Stores Inc is far larger — about 31.9× DexCom, Inc.'s market cap, and Walmart Stores Inc pays a 0.88% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WMT | |
|---|---|---|
Market Cap | $28.06B | $895.52B |
Sector | Health | Consumer Staples |
52-Week High | $89.53 | $134.20 |
52-Week Low | $54.84 | $95.05 |
Enterprise Value | $27.03B | $958.97B |
Volume | — | 5,675,288 |
Dividend Yield | — | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Walmart (WMT) trades at $113.70, down 0.94% on the day, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $0.74. Revenue grew to $681.0B in 2025, and net income margin improved to 2.85%. Recent news highlights Walmart's AI initiatives and philanthropic efforts, while technical indicators point to near-term resistance at $115.
The outlook for WMT is positive based on robust fundamentals and analyst consensus, with a price target of $142.10 implying 25% upside. Risks include competitive pressure from Amazon and potential legal issues from recent lawsuits. Institutional sentiment remains bullish, supporting long-term growth prospects amid near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
